NCT06433479View on ClinicalTrials.gov

Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Atrial Fibrillation
Interventions
DRUG

Dapagliflozin 10 mg per day for 3 months after initial catheter ablation

Dapagliflozin 10 mg per day for 3 months after initial catheter ablation

Trial Locations (1)

100029

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER

NCT06433479 - Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation | Biotech Hunter | Biotech Hunter